96 related articles for article (PubMed ID: 1670786)
1. Migration stimulating activity in serum of breast cancer patients.
Picardo M; Schor SL; Grey AM; Howell A; Laidlaw I; Redford J; Schor AM
Lancet; 1991 Jan; 337(8734):130-3. PubMed ID: 1670786
[TBL] [Abstract][Full Text] [Related]
2. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
3. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro.
Haggie JA; Sellwood RA; Howell A; Birch JM; Schor SL
Lancet; 1987 Jun; 1(8548):1455-7. PubMed ID: 2885452
[TBL] [Abstract][Full Text] [Related]
6. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
7. Influence of serum on adult and fetal dermal fibroblast migration, adhesion, and collagen expression.
Brink HE; Stalling SS; Nicoll SB
In Vitro Cell Dev Biol Anim; 2005; 41(8-9):252-7. PubMed ID: 16409110
[TBL] [Abstract][Full Text] [Related]
8. Foetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer.
Schor SL; Schor AM
J Cell Sci Suppl; 1987; 8():165-80. PubMed ID: 3332659
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer.
Fuksiewicz M; Kowalska M; Kotowicz B; Rubach M; Chechlinska M; Pienkowski T; Kaminska J
Clin Chem Lab Med; 2010 Oct; 48(10):1481-6. PubMed ID: 20578967
[TBL] [Abstract][Full Text] [Related]
10. Serum-dependent effects on adult and fetal tendon fibroblast migration and collagen expression.
Brink HE; Miller GJ; Beredjiklian PK; Nicoll SB
Wound Repair Regen; 2006; 14(2):179-86. PubMed ID: 16630107
[TBL] [Abstract][Full Text] [Related]
11. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of a fetal fibroblast phenotype in familial breast cancer.
Schor SL; Haggie JA; Durning P; Howell A; Smith L; Sellwood RA; Crowther D
Int J Cancer; 1986 Jun; 37(6):831-6. PubMed ID: 3710614
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study.
Jaurila H; Koivukangas V; Koskela M; Gäddnäs F; Salo S; Korvala J; Risteli M; Karhu T; Herzig KH; Salo T; Ala-Kokko TI
J Transl Med; 2017 Jan; 15(1):11. PubMed ID: 28086962
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms affecting neutrophil migration capacity in breast cancer patients before and after chemotherapy.
Mendonça MA; Souto FO; Micheli DC; Alves-Filho JC; Cunha FQ; Murta EF; Tavares-Murta BM
Cancer Chemother Pharmacol; 2014 Feb; 73(2):317-24. PubMed ID: 24258454
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
Suchanski J; Tejchman A; Zacharski M; Piotrowska A; Grzegrzolka J; Chodaczek G; Nowinska K; Rys J; Dziegiel P; Kieda C; Ugorski M
PLoS One; 2017; 12(9):e0184970. PubMed ID: 28938000
[TBL] [Abstract][Full Text] [Related]
17. Cell migration influences collagen gel contraction.
Andujar MB; Melin M; Guerret S; Grimaud JA
J Submicrosc Cytol Pathol; 1992 Apr; 24(2):145-54. PubMed ID: 1600506
[TBL] [Abstract][Full Text] [Related]
18. Characterization of migration-stimulating factor (MSF): evidence for its role in cancer pathogenesis.
Schor SL; Schor AM
Cancer Invest; 1990; 8(6):665-7. PubMed ID: 2292062
[No Abstract] [Full Text] [Related]
19. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
Ławicki S; Będkowska GE; Wojtukiewicz M; Szmitkowski M
Adv Med Sci; 2013; 58(2):207-15. PubMed ID: 23846151
[TBL] [Abstract][Full Text] [Related]
20. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]